Published by Coherent Market Insights
Posted on September 21, 2021
4 min readLast updated: February 4, 2026
The Lab-on-a-chip market is set to grow at a 16.2% CAGR from 2021 to 2027, driven by its cost-saving and diagnostic speed benefits in healthcare.
Global Lab-on-a-chip Market – Insights
Lab-on-a-chip (LoC) is the integration of various analyses, biochemical operations, and DNA sequencing on a single chip. The approach has gained increasing preference due to its ability to save costs and enhance diagnostic speed. LoC can perform single or multiple laboratory functions on a chip that may measure a few millimeters or square centimeters. LoC requires integration of optics, electronics, biosensors, and fluidics.
Global Lab-on-a-chip Market: Drivers
Increasing adoption of LoC in the diagnosis of various infections and chronic diseases is expected to boost growth of the global lab-on-a-chip market over the forecast period. LoC devices are portable and offer automated sample handling and re-configurability. These devices offer rapid and on-time diagnosis results and are therefore used for point-of-care diagnosis. Moreover, microfluidic LoCs enable the miniaturization, integration, and automation of biochemical assays. This in turn facilitates their use in biomedical and healthcare sectors, which is also expected to boost growth of the market. Some of the applications of LoC technology in the biomedical field include, immunoassay LoC for bacteria detection, DNA chip, gene chip, real time PCR detection chips, cellular analysis chip, and flow cytometer LoC (for HIV). Moreover, recent development in the computational simulations field has facilitated synthesis of inorganic nanomaterials-based on nanomedicine in a single construct using LoC technology. The approach is used in theranostic applications that focus on combining specific targeted therapy based on specific targeted diagnostic tests.
Request for Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/515
Increasing prevalence of cancer is expected to fuel growth of the global lab-on-a-chip market. For instance, according to the Centers for Disease Control and Prevention, in 2012, nearly 40,000 new cases of cancer of the oral cavity and pharynx were diagnosed in the U.S. and the disease resulted in nearly 9,000 deaths. LoC devices are used for the biomarker-based identification and early detection of oral cancer. LoC is also used in detection of pathogens. Therefore, high incidence of malaria, swine flu, zika virus, and Ebola virus is also expected to boost growth of the market. For instance, according to the World Health Organization (WHO), in 2015, nearly half of the world’s population was at risk of malaria and around 212 million malaria cases were reported.
Increasing R&D to expand the use of LoC is expected to contribute to growth of the market. For instance, according to data published in International Journal of Bio-Science and Bio-Technology, 2016, researchers suggested that LoC is a potential technology that can aid in development of novel approach for the treatment of central nervous system disorders such as Parkinson’s disease and spinal cord injury. LoC can be used to extract sufficient cerebrospinal fluid needed to perform conventional assays.
Statics:
The global lab-on-a-chip market size was valued at US$ 5,175.4 million in 2019, and is expected to witness a CAGR of 10.5% over the forecast period (2019 – 2027).
Global Lab-on-a-chip Market: Regional Analysis
North America is expected to hold dominant position in the global lab-on-a-chip market, followed by Europe, over the forecast period. This is owing to high adoption of LoC and increasing R&D in the technology.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/515
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Increasing population prone to viral diseases is expected to boost growth of the market in Asia Pacific. For instance, according to Joint United Nations Program on HIV/AIDS (UNAIDS) reports 2013, in Asia Pacific, over 350,000 people were infected with HIV with nearly 5 million living with HIV/AIDS.
Global Lab-on-a-chip Market: Competitive Landscape
Key players operating in the global lab-on-chip market include, Nobel Biocare Services AG, Takara Bio Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., and Cepheid Inc.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Lab-on-a-chip Market was valued at US$ 5,175.4 million in 2020 and is expected to witness a robust CAGR of 16.2% over the forecast period (2021 – 2027) appeared first on Gatorledger.
The article discusses the growth and applications of the Lab-on-a-chip market, focusing on its role in diagnostics and healthcare.
The market is growing due to its cost-saving benefits and enhanced diagnostic speed, particularly in point-of-care settings.
North America and Europe are leading in the adoption and research of Lab-on-a-chip technology.
Explore more articles in the Research Reports category
